Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study

Automated data extraction—A feasible way to construct patient registers of primary care utilization

(2012) Mats Martinell et al.   UPSALA JOURNAL OF MEDICAL SCIENCES

Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study

(2011) C. R. Jenkins et al.   EUROPEAN RESPIRATORY JOURNAL

A new perspective on optimal care for patients with COPD

(2011) Dirkje Postma et al.   Primary Care Respiratory Journal

Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management

(2011) Melissa Roberts et al.   JOURNAL OF MEDICAL ECONOMICS

Bias due to withdrawal in long-term randomised trials in COPD: Evidence from the TORCH study

(2010) Jørgen Vestbo et al.   Clinical Respiratory Journal

Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence

(2010) Lucie Blais et al.   CLINICAL THERAPEUTICS

Cardiovascular Events in Subgroups of Patients During Primary Treatment of Hypertension With Candesartan or Losartan

(2010) David Russell et al.   Journal of Clinical Hypertension

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

(2010) John R. Hurst et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension

(2009) S E Kjeldsen et al.   JOURNAL OF HUMAN HYPERTENSION

Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD

(2009) Martyn R. Partridge et al.   Therapeutic Advances in Respiratory Disease

The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide

(2007) Jadwiga A. Wedzicha et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE